Table 1.
Demographic and clinical data of the patients at baseline.
| Patients with RA | Patients with PsA | |||
|---|---|---|---|---|
| MTX group | Etanercept group | MTX group | Etanercept group | |
| Patient, N (females) | 7 (5) | 5 (4) | 5 (2) | 5 (1) |
| Age, mean (SD) | 45.7 (11.7) | 60.0 (10) | 45.4 (14.1) | 50.2 (11) |
| Disease duration (months), mean (SD) | 1.7 (0.2) | 26.8 (9.5) | 1.8 (0.3) | 33 (9.5) |
| DAS28, mean (SD) | 6.6 (0.9) | 6.7 (0.9) | 5.4 (0.7) | 5.3 (0.6) |
| BMD of the examined joint, mean (SD) | 0.291 (0.067) | 0.319 (0.028) | 0.340 (0.018) | 0.363 (0.057) |
PDUS: power Doppler US. DAS values between groups were not statistically significant.